Cytoreduction and Hyperthermic Intraperitoneal Paclitaxel and Cisplatin for Gastric Cancer with Peritoneal Metastasis

Background Peritoneal metastasis (PM) is the most common site of dissemination of gastric cancer (GC) and is associated with a poor prognosis. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for GC with PM remains controversial due to modest survival and significant...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of surgical oncology 2024, Vol.31 (1), p.622-629
Hauptverfasser:	Buckarma, EeeLN, Thiels, Cornelius A., Jin, Zhaohui, Grotz, Travis E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Anastomotic leak Antineoplastic Combined Chemotherapy Protocols - therapeutic use Chemoradiotherapy Chemotherapy Cisplatin Combined Modality Therapy Cytoreduction Surgical Procedures Gastric cancer Humans Hyperthermia, Induced Laparoscopy Medical prognosis Medicine Medicine & Public Health Metastases Metastasis Morbidity Oncology Paclitaxel Peritoneal Neoplasms - secondary Peritoneal Surface Malignancy Peritoneum Retrospective Studies Stomach Neoplasms - pathology Surgery Surgical anastomosis Surgical Oncology Survival Survival Rate Terminology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!